Adverum Biotechnologies (ADVM) Tops Q2 EPS by 6c

August 8, 2019 4:40 PM

Adverum Biotechnologies (NASDAQ: ADVM) reported Q2 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found